SARIL-RA-MONARCH Trial Reveals Sarilumab's Superiority to Adalimumab Through PROs
AJMC,
The SARIL-RA-MONARCH trial has shown that sarilumab has greater impact on many patient-reported outcomes (PROs) than adalimumab…
The SARIL-RA-MONARCH trial has shown that sarilumab has greater impact on many patient-reported outcomes (PROs) than adalimumab…
03-07-2018 | Rheumatology | News | Article medwireNews: Patients with rheumatoid arthritis (RA) have reported greater…
Monotherapy with sarilumab (Kevzara) showed greater efficacy on patient-reported outcomes among adults with rheumatoid…